Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05449418 · ClinicalTrials.gov registry record · NA
Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities
A NA study of COVID-19, sponsored by Kaiser Permanente.
- Active
- Registry status
- NA
- Development phase
- 988
- Enrollment target
- 2
- Study locations
NCT05449418: Active NA study of COVID-19, sponsored by Kaiser Permanente.
NCT05449418 is a NA study of COVID-19 that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 988 participants, below the 38,462-participant average among 298 other COVID-19 trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05449418, a NA study of COVID-19, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 988 participants
- Enrollment target
- 2
- Study locations
Study Summary
The ENSPIRE study is a cluster-randomized comparative effectiveness trial being conducted within long-term care and residential facilities that will test a communication and engagement strategy for increasing COVID-19 booster vaccination rates against an enhanced usual care comparator (Centers for Disease Control and Prevention or other national organization vaccine education and communication materials) among facility staff. The communication and engagement strategy being tested includes (1) the development of materials co-designed with and tailored to facility staff whose primary language is a language other than English or who are from certain cultural affinity groups and (2) the distribution of the developed materials by members of the language/cultural affinity groups with peer advocacy activities (full intervention). The study is being conducted in Washington state and Georgia. Long-term care/residential facilities will be asked to furnish their staff booster rate at 4 timepoints: pre-intervention, and one month (timepoint 1), 3 months (timepoint 2), and 6 months (timepoint 3) post-intervention. Staff at participating long-term care facilities will be invited to complete three online surveys at 3 timepoints: pre-intervention, 3 months post-intervention and 6 months post-intervention. Long-term care facilities will be randomized to a trial arm following the pre-intervention data collection.
Primary Outcome
Change in percentage of staff at long-term care centers that have received a booster vaccine over time.
Conditions Studied
Interventions
- OTHER Enhanced Usual Care
- BEHAVIORAL Full Intervention
Study Locations (2)
Georgia
- Kaiser Permanente Georgia Center for Research and Evaluation - Atlanta
Washington
- Kaiser Permanente Washington Health Research Institute - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 988 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What the registry record for NCT05449418 still lists
NCT05449418 is an interventional study that assigns participants to a tested intervention. The registered 988 participants enrollment target is mid-sized for trials with a published cap, below the 38,462-participant average among 298 other COVID-19 trials with a reported enrollment target (97% lower).
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT05449418 reports a single indexed study location in Georgia, Washington.
Frequently Asked Questions
What is clinical trial NCT05449418 about?
NCT05449418 is a clinical study titled "Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities". The ENSPIRE study is a cluster-randomized comparative effectiveness trial being conducted within long-term care and residential facilities that will test a communication and engagement strategy for increasing COVID-19 booster vaccination rates against an enhanced usual care comparator (Centers for D...
What is the current status of trial NCT05449418?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 988 participants. The study started on 2021-08-01. Estimated completion is 2026-02-28.
What conditions does trial NCT05449418 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT05449418?
The interventions under investigation include: Enhanced Usual Care (OTHER), Full Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05449418?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05449418 being conducted?
This trial has 2 study locations across Georgia, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05449418's enrollment target sits among peer trials
988 79th of 298 higher than 220 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079841 · 988 participants · Phase 4
The Stimulation To Induce Mothers Study
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
- NCT06340646 · 990 participants · NA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- NCT06878261 · 990 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI